Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1323101.RA5XBZgkSF75deaWP_icxEQT60VC1ascsg6JMoHHZPwhs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1323101.RA5XBZgkSF75deaWP_icxEQT60VC1ascsg6JMoHHZPwhs130_assertion type Assertion NP1323101.RA5XBZgkSF75deaWP_icxEQT60VC1ascsg6JMoHHZPwhs130_head.
- NP1323101.RA5XBZgkSF75deaWP_icxEQT60VC1ascsg6JMoHHZPwhs130_assertion description "[A significant relation was observed between presence of chromosome abnormalities and the following hematologic parameters: clinical stage III (p = 0.0212), bone marrow (BM) plasma cell infiltration greater than 30% (p = 0.0379), presence of bone lesions (p = 0.0051), and beta 2-microglobulin levels greater than 4,000 md/dl (p = 0.0194).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1323101.RA5XBZgkSF75deaWP_icxEQT60VC1ascsg6JMoHHZPwhs130_provenance.
- NP1323101.RA5XBZgkSF75deaWP_icxEQT60VC1ascsg6JMoHHZPwhs130_assertion evidence source_evidence_literature NP1323101.RA5XBZgkSF75deaWP_icxEQT60VC1ascsg6JMoHHZPwhs130_provenance.
- NP1323101.RA5XBZgkSF75deaWP_icxEQT60VC1ascsg6JMoHHZPwhs130_assertion SIO_000772 7828155 NP1323101.RA5XBZgkSF75deaWP_icxEQT60VC1ascsg6JMoHHZPwhs130_provenance.
- NP1323101.RA5XBZgkSF75deaWP_icxEQT60VC1ascsg6JMoHHZPwhs130_assertion wasDerivedFrom befree-2016 NP1323101.RA5XBZgkSF75deaWP_icxEQT60VC1ascsg6JMoHHZPwhs130_provenance.
- NP1323101.RA5XBZgkSF75deaWP_icxEQT60VC1ascsg6JMoHHZPwhs130_assertion wasGeneratedBy ECO_0000203 NP1323101.RA5XBZgkSF75deaWP_icxEQT60VC1ascsg6JMoHHZPwhs130_provenance.